Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 152, Issue , 2015, Pages 62-75

  Mahmoud, Abeer M ^a   Al Alem, Umaima ^b   Ali, Mohamed M ^b   Bosland, Maarten C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Estrogen receptor ; Genistein; Promoter methylation; Prostate cancer

Indexed keywords

ESTROGEN RECEPTOR BETA; GENISTEIN; 4-(2-PHENYL-5,7-BIS(TRIFLUOROMETHYL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)PHENOL; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; LAPC 4 CELL LINE; LNCAP CELL LINE; MALE; MODULATION; MOUSE; NONHUMAN; PC 3 CELL LINE; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; ACTIVE TRANSPORT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DNA METHYLATION; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PROMOTER REGION; PROSTATIC NEOPLASMS; RNA INTERFERENCE; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; ESTROGEN RECEPTOR BETA; GENISTEIN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84928818101     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.04.018     Document Type: Article

References (65)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, and E. Ward et al. Global cancer statistics CA Cancer J. Clin. 61 2011 69 90
2. R. Siegel, C. Desantis, K. Virgo, K. Stein, and A. Mariotto et al. Cancer treatment and survivorship statistics CA Cancer J. Clin. 62 2012 220 241
3. T. Kimura East meets west: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians Chin. J. Cancer 31 9 2012 421 429
4. H. Adlercreutz, H. Markkanen, and S. Watanabe Plasma concentrations of phyto-oestrogens in Japanese men Lancet 342 1993 1209 1210
5. M.S. Morton, P.S. Chan, C. Cheng, N. Blacklock, and A. Matos-Ferreira et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom Prostate 32 1997 122 128
6. Y.W. Hwang, S.Y. Kim, S.H. Jee, Y.N. Kim, and C.M. Nam Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies Nutr. Cancer 61 2009 598 606
7. L. Yan, and E.L. Spitznagel Meta-analysis of soy food and risk of prostate cancer in men Int. J. Cancer 117 2005 667 669
8. L. Jian Soy, isoflavones, and prostate cancer Mol. Nutr. Food Res. 53 2009 217 226
9. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, and S.H. Safe et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263
10. K. Morito, T. Hirose, J. Kinjo, T. Hirakawa, and M. Okawa et al. Interaction of phytoestrogens with estrogen receptors alpha and beta Biol. Pharm. Bull. 24 2001 351 356
11. J. Bektic, A.P. Berger, K. Pfeil, G. Dobler, and G. Bartsch et al. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta Eur. Urol. 45 2004 245 251 (discussion 251)
12. Z. Weihua, S. Makela, L.C. Andersson, S. Salmi, and S. Saji et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc. Natl. Acad. Sci. U. S. A. 98 2001 6330 6335
13. O. Imamov, A. Morani, G.J. Shim, Y. Omoto, and C. Thulin-Andersson et al. Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate Proc. Natl. Acad. Sci. U. S. A. 101 2004 9375 9380
14. S.J. McPherson, S. Hussain, P. Balanathan, S.L. Hedwards, and B. Niranjan et al. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated Proc. Natl. Acad. Sci. U. S. A. 107 2010 3123 3128
15. S.M. Ho Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates J. Cell. Biochem. 91 2004 491 503
16. I. Leav, K.M. Lau, J.Y. Adams, J.E. McNeal, and M.E. Taplin et al. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma Am. J. Pathol. 159 2001 79 92
17. M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, and I. Kotcherguina et al. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer J. Natl. Cancer Inst. 94 2002 384 390
18. T.J. Walton, G. Li, R. Seth, S.E. McArdle, and M.C. Bishop et al. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines Prostate 68 2008 210 222
19. K.M. Lau, M. LaSpina, J. Long, and S.M. Ho Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation Cancer Res. 60 2000 3175 3182
20. A. Rody, U. Holtrich, C. Solbach, K. Kourtis, and G. von Minckwitz et al. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions Endocr. Relat. Cancer 12 2005 903 916
21. X. Zhu, I. Leav, Y.K. Leung, M. Wu, and Q. Liu et al. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis Am. J. Pathol. 164 2004 2003 2012
22. M. Adjakly, R. Bosviel, N. Rabiau, J.P. Boiteux, and Y.J. Bignon et al. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines Epigenomics 3 2011 795 803
23. A. Vardi, R. Bosviel, N. Rabiau, M. Adjakly, and S. Satih et al. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells In Vivo 24 2010 393 400
24. S. Majid, A.A. Dar, V. Shahryari, H. Hirata, and A. Ahmad et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-cell translocation gene 3 in prostate cancer Cancer 116 2010 66 76
25. N. Kikuno, H. Shiina, S. Urakami, K. Kawamoto, and H. Hirata et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells Int. J. Cancer 123 2008 552 560
26. R. Kumar, V. Verma, A. Jain, R.K. Jain, and J.P. Maikhuri et al. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer J. Nutr. Biochem. 22 2011 723 731
27. A. Slusarz, G.A. Jackson, J.K. Day, N.S. Shenouda, and J.L. Bogener et al. Aggressive prostate cancer is prevented in ERalphaKO mice and stimulated in ERbetaKO TRAMP mice Endocrinology 153 2012 4160 4170
28. K.A. Klein, R.E. Reiter, J. Redula, H. Moradi, and X.L. Zhu et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice Nat. Med. 3 1997 402 408
29. S.K. Patra, A. Patra, F. Rizzi, T.C. Ghosh, and S. Bettuzzi Demethylation of (cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development Cancer Metastasis Rev. 27 2008 315 334
30. L.C. Li, C.C. Yeh, D. Nojima, and R. Dahiya Cloning and characterization of human estrogen receptor beta promoter Biochem. Biophys. Res. Commun. 275 2000 682 689
31. G.P. Skliris, K. Munot, S.M. Bell, P.J. Carder, and S. Lane et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model J. Pathol. 201 2003 213 220
32. C. Zhao, E.W. Lam, A. Sunters, E. Enmark, and M.T. De Bella et al. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 2003 7600 7606
33. H. Al-Nakhle, L. Smith, S.M. Bell, P.A. Burns, and M. Cummings et al. Regulation of estrogen receptor beta1 expression in breast cancer by epigenetic modification of the 5′ regulatory region Int. J. Oncol. 43 2013 2039 2045
34. J. Turek-Plewa, and P.P. Jagodzinski The role of mammalian DNA methyltransferases in the regulation of gene expression Cell. Mol. Biol. Lett. 10 2005 631 647
35. S.K. Patra, A. Patra, H. Zhao, and R. Dahiya DNA methyltransferase and demethylase in human prostate cancer Mol. Carcinog. 33 2002 163 171
36. G.L. Gravina, F. Marampon, M. Piccolella, M. Motta, and L. Ventura et al. Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models Endocrinology 152 2011 4550 4561
37. Y. Kobayashi, D.M. Absher, Z.G. Gulzar, S.R. Young, and J.K. McKenney et al. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer Genome Res. 21 2011 1017 1027
38. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, and J. Haggblad et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870
39. M. Nadal-Serrano, D.G. Pons, J. Sastre-Serra, M. Blanquer-Rossello Mdel, and P. Roca et al. Genistein modulates oxidative stress in breast cancer cell lines according to ERalpha/ERbeta ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes Int. J. Biochem. Cell Biol. 45 2013 2045 2051
40. B.T. Zhu, G.Z. Han, J.Y. Shim, Y. Wen, and X.R. Jiang Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding Endocrinology 147 2006 4132 4150
41. E. Enmark, M. Pelto-Huikko, K. Grandien, S. Lagercrantz, and J. Lagercrantz et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern J. Clin. Endocrinol. Metab. 82 1997 4258 4265
42. A. Cvoro, D. Tatomer, M.K. Tee, T. Zogovic, and H.A. Harris et al. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes J. Immunol. 180 2008 630 636
43. H.M. Lam, C.V. Suresh Babu, J. Wang, Y. Yuan, and Y.W. Lam et al. Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion Mol. Cell. Endocrinol. 358 2012 27 35
44. Y.K. Leung, and S.M. Ho Estrogen receptor beta: switching to a new partner and escaping from estrogen Sci. Signal. 4 2011 pe19
45. D.R. Compton, S. Sheng, K.E. Carlson, N.A. Rebacz, and I.Y. Lee et al. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity J. Med. Chem. 47 2004 5872 5893
46. A.M. Mahmoud, W. Yang, and M.C. Bosland Soy isoflavones and prostate cancer: a review of molecular mechanisms J. Steroid Biochem. Mol. Biol. 140 2014 116 132
47. L.C. Li, H. Zhao, K. Nakajima, B.R. Oh, and L.A. Ribeiro Filho et al. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer J. Urol. 166 2001 705 709
48. H. Enokida, H. Shiina, S. Urakami, M. Igawa, and T. Ogishima et al. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer Int. J. Cancer 116 2005 174 181
49. S. Hirata, T. Shoda, J. Kato, and K. Hoshi The multiple untranslated first exons system of the human estrogen receptor beta (ER beta) gene J. Steroid Biochem. Mol. Biol. 78 2001 33 40
50. D.J. Stewart, J.P. Issa, R. Kurzrock, M.I. Nunez, and J. Jelinek et al. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas Clin. Cancer Res. 15 2009 3881 3888
51. R.E. George, J.M. Lahti, P.C. Adamson, K. Zhu, and D. Finkelstein et al. Phase I. study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study Pediatr. Blood Cancer 55 2010 629 638
52. E. Raffoux, A. Cras, C. Recher, P.Y. Boelle, and A. de Labarthe et al. Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome Oncotarget 1 2010 34 42
53. J.K. Christman 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy Oncogene 21 2002 5483 5495
54. L. Zhou, X. Cheng, B.A. Connolly, M.J. Dickman, and P.J. Hurd et al. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases J. Mol. Biol. 321 2002 591 599
55. A. Bird DNA methylation patterns and epigenetic memory Genes Dev. 16 2002 6 21
56. Q. Xie, Q. Bai, L.Y. Zou, Q.Y. Zhang, and Y. Zhou et al. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells Genes Chromosomes Cancer 53 2014 422 431
57. S. Agarwal, K.S. Amin, S. Jagadeesh, G. Baishay, and P.G. Rao et al. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells Mol. Cancer 12 2013 99
58. Y. Nakajima, K. Akaogi, T. Suzuki, A. Osakabe, and C. Yamaguchi et al. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5 Sci. Signal. 4 2011 ra22
59. A. Tremblay, G.B. Tremblay, F. Labrie, and V. Giguere Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1 Mol. Cell 3 1999 513 519
60. Y. Nakamura, S.J. Felizola, Y. Kurotaki, F. Fujishima, and K.M. McNamara et al. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERbeta) in human prostate cancer Prostate 73 6 2013 590 595
61. A.M. Mahmoud, T. Zhu, A. Parray, H.R. Siddique, and W. Yang et al. Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor PLoS One 8 2013 e78479
62. T. Ito, M. Tachibana, S. Yamamoto, J. Nakashima, and M. Murai Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer Eur. Urol. 40 2001 557 563
63. A. Latil, I. Bieche, D. Vidaud, R. Lidereau, and P. Berthon et al. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res. 61 2001 1919 1926
64. G. Megas, M. Chrisofos, I. Anastasiou, A. Tsitlidou, and T. Choreftaki et al. Estrogen receptor (alpha and beta) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population Asian J. Androl. 17 2015 98 105
65. A. Thibault, W.D. Figg, R.C. Bergan, R.M. Lush, and C.E. Myers et al. A phase II study of 5-aza-2′deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer Tumori 84 1998 87 89